These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 595698)

  • 21. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
    Moggia AV
    J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with a low-dose contraceptive agent. European studies.
    Haspels AA
    J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
    Goldzieher JW
    J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.
    Larrañaga A; Sartoretto JN; Winterhalter M; Navas Filho F
    Int J Fertil; 1978; 23(3):193-9. PubMed ID: 40893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between thrombolytic therapy and liver rupture?].
    Pansold E; Dzikonski M; Heinrich HG; Schneider J
    Z Arztl Fortbild (Jena); 1985; 79(13):575-6. PubMed ID: 4036189
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphologic changes in the epithelium of the uterine cervix in long-term administration of the 19-norsteroid-containing oral hormonal contraceptives Non-Ovlon and gravistat].
    Geissler U
    Zentralbl Gynakol; 1988; 110(5):267-76. PubMed ID: 2453979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of tobacco and oral contraception in myocardial infarction in the female. Description of a case].
    Leone A; Lopez M
    Pathologica; 1984; 76(1044):493-8. PubMed ID: 6440110
    [No Abstract]   [Full Text] [Related]  

  • 30. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
    Orlandi F; Cattaneo C; Gabasio S; Spandre M; Paccotti P; Rustichelli S
    Arch Sci Med (Torino); 1978; 135(4):609-17. PubMed ID: 756722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary embolism in a woman taking oral contraceptives and valdecoxib.
    Westgate EJ; Fitzgerald GA
    PLoS Med; 2005 Jul; 2(7):e197. PubMed ID: 16013893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility control with norgestrel and ethynil estradiol. Report on continuing studies.
    Rice-Wray E; Cervantes A; Garcilazo J; Valenzuela P
    J Reprod Med; 1972 Aug; 9(2):45-9. PubMed ID: 5050402
    [No Abstract]   [Full Text] [Related]  

  • 34. [Risks of postcoital contraception using a d-norgestrel-ethinyl estradiol combination].
    Welti H; Nguyen Duy N; Zufferey MM
    Ther Umsch; 1986 May; 43(5):438-40. PubMed ID: 3726780
    [No Abstract]   [Full Text] [Related]  

  • 35. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
    Rubio-Lotvin B; Gonzales-Ansorena R
    Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Jaundice after ovulation inhibiting steroids].
    Fritsch H; Kaess H
    Med Klin; 1969 May; 64(19):894-7. PubMed ID: 5772231
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
    Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
    Woutersz TB
    J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovral as a "morning-after" contraceptive.
    Med Lett Drugs Ther; 1989 Oct; 31(803):93-4. PubMed ID: 2796842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.